Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
Clinical trial NCT00499369 · TERMINATED
Trial details
- NCT number
- NCT00499369
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2012-11-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.